DESIGN CONTROLS CITED IN HALF OF ALL QUALITY SYSTEM WARNING LETTERS IN 2005, BUT FDA SAYS FIRMS HAVE MADE GREAT PROGRESS IN PAST 10 YEARS
This article was originally published in The Silver Sheet
Executive Summary
NEARLY TEN YEARS AFTER FDA REQUIRED DESIGN CONTROLS by way of the Quality System Regulation, statistics show that some manufacturers still are not meeting the requirements, with half of all quality system warning letters issued in 2005 containing some sort of design control violation. However, experts agree that companies’ attitudes toward design controls have come a long way since the regulation was published in 1996. CDRH Quality Systems Expert Kim Trautman says the agency still believes strongly in the flexibility built into the design control requirements, but notes that this flexibility also can lead to trouble for firms that don’t play by the rules. "We’re giving manufacturers a rope," she says. "They can either use that rope for good ... or they can hang themselves with that rope when they don’t use it wisely"... 2006 COULD BRING SOME IMPORTANT CHANGES to the device industry, including stricter postmarket surveillance and an intensified focus on risk management, experts predict...
You may also be interested in...
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.
FDA Slaps High Risk Class I Label On Recall Of COVID-19 Diagnostics Made In Uncontrolled Plant
More than 160,000 of the tests were recalled, including 104,900 COVID Test Kits Nonsterile and 61,500 Clean Catch Urine Kits.